Overview
Global Medical Lead Early Assets role at Grünenthal Group.
Join our team to drive medical leadership for early assets, with a focus on building partnerships with patient groups, external stakeholders and cross-functional teams to advance patient care in line with Grünenthal’s vision to reduce pain worldwide.
Responsibilities
* Establishing the KEE, patient Organization and Scientific Societies network in DMD
* Provides PAG engagement plan and engages with PAGs, supports with KEE engagement plan and engages with KEEs including the organization of patient and KEE advisory boards
* Works in close collaboration with the Global Medical Lead Early Assets, R&D project lead, and the commercial lead for early products to define the TPP and product hypothesis that will drive development efforts
* Similarly, works with the early stage diligence team to crystalize the potential value of a R&D–stage product by defining the TPP, product hypothesis to enable positioning in most appropriate area of relevant medical need
* Guides & leads scientific discussions, incl. further study program and LCM initiatives aimed at enhancing outcomes e.g. identify patient profiles with highest benefit from intervention/treatment
* Develops scientific/medical story flow and scientific narratives, including scientific messaging accuracy and dissemination across stakeholders in line with patient journey, unmet needs
* Understands the competitive landscape and provides regular reports and training on the matter across the business
* Aligns evidence generation planning with regulatory, clinical, and commercial goals. Identifies evidence gaps for regulators, payers, prescribers, and patients
* Outlines clinical trials, real-world studies, HEOR, biomarker research, etc. Connects insights across R&D, Medical Affairs, and Commercial functions
Qualifications
* Experience in interacting with PAG in rare diseases. Experience with DMD PAGs as a plus
* Passionate about connecting with External Stakeholders and building strong network with KEE, Patient Advocacy Groups and relevant stakeholders
* Excellent understanding of clinical practice, guidelines and existing standards in rare diseases / DMD
* Experience in early products evaluation and drug development
* Comprehensive knowledge of applicable compliance, legal & regulatory requirements
* Thorough medical and scientific acumen
* Passionate about medical affairs and creating value for patients and seeking insights into real clinical practice
* Preferably knowledgeable about biological pathways of DMD disease and available therapies
* Preferably knowledge in building Integrated Evidence Plans and working closely with US
#J-18808-Ljbffr